Haifa, Israel

Dana Egozi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Technion Research & Development Foundation Ltd. Active years: 2021.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dana Egozi: Innovator in Tissue Regeneration

Introduction

Dana Egozi is a notable inventor based in Haifa, Israel. He has made significant contributions to the field of tissue engineering, particularly in the area of soft tissue regeneration. His innovative work has the potential to impact medical treatments for patients with large soft tissue defects.

Latest Patents

Dana Egozi holds a patent for a groundbreaking invention titled "Flap for de-novo tissue regeneration." This patent describes an implant that includes an autologous engineered tissue and a vasculature. The engineered tissue is a porous scaffold embedded with various cell types, including endothelial cells, fibroblasts, myoblasts, mesenchymal cells, and adipocytes. The vasculature is designed to nourish these cells, enhancing the effectiveness of the implant. This invention provides a method for treating subjects afflicted with significant soft tissue defects by utilizing the implant.

Career Highlights

Throughout his career, Dana Egozi has worked with esteemed organizations, including the Technion Research & Development Foundation Ltd and Rambam Health Care Campus. His experience in these institutions has allowed him to develop and refine his innovative ideas in tissue engineering.

Collaborations

Dana Egozi has collaborated with notable colleagues, including Jacob Koffler and Shulamit Levenberg. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Dana Egozi's contributions to tissue regeneration through his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to significantly improve treatment options for patients with soft tissue injuries.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…